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Abstract
Background: Patterns in time, place and cause of death can have an important impact on calculated hospital
mortality rates. Objective is to quantify these patterns following myocardial infarction and stroke admissions in
Dutch hospitals during the period 1996–2003, and to compare trends in the commonly used 30-day in-hospital
mortality rates with other types of mortality rates which use more extensive follow-up in time and place of death.
Methods: Discharge data for all Dutch admissions for index conditions (1996–2003) were linked to the death
certification registry. Then, mortality rates within the first 30, 90 and 365 days following admissions were analyzed
for deaths occurring within and outside hospitals.
Results: Most deaths within a year after admission occurred within 30 days (60–70%). No significant trends in
this distribution of deaths over time were observed. Significant trends in the distribution over place of death were
observed for both conditions. For myocardial infarction, the proportion of deaths after transfer to another
hospital has doubled from 1996–2003. For stroke a significant rise of the proportion of deaths outside hospital
was found. For MI the proportion of deaths attributed to a circulatory disease has significantly fallen ovtime. Seven
types of hospital mortality indicators, different in scope and observation period, all show a drop of hospital
mortality for both MI and stroke over the period 1996–2003. For stroke the observed absolute reduction in death
rate increases for the first year after admission, for MI the observed drop in 365-day overall mortality almost
equals the observed drop in 30-day in hospital mortality over 1996–2003.
Conclusion: Changes in the timing, place and causes of death following admissions for myocardial infarction and
stroke have important implications for the definitions of in-hospital and post-admission mortality rates as
measures of hospital performance. Although necessary for understanding mortality patterns over time, including
within mortality rates deaths which occur outside hospitals and after longer periods following index admissions
remain debatable and may not reflect actual hospital performance but probably mirrors transfer, efficiency, and
other health care policies.
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Background
Mortality after admission is seen as an important indica-
tor of hospital performance, and forms part of several sets
of quality indicators [1,2]. Some systems of measuring
hospital performance even rely exclusively on post-admis-
sion mortality rates to rank hospital quality [3]. However,
there are several pitfalls when it comes to calculating these
indicators. The first question to consider is the influence
of trends in place and time of death on hospital mortality
statistics. An observed decline in hospital mortality after a
myocardial infarction (MI) or stroke could indicate better
care, but could also point to earlier discharge or to an
increased transfer between hospitals, with death occurring
after discharge or transfer. For Canada it has been shown
that excluding transfer cases changes performance ranking
for MI [4]. A related problem is the risk of administrative
errors related to transfer. An American study revealed that
double counting of patients in routine statistics occurred
in 10–15% of all inter-hospital transfer cases, which sig-
nificantly influenced both hospitalization and mortality
rates [5]. It has been argued that the influence of transfer
on hospital mortality statistics has grown in recent years,
due to the shortening of length of stay [6]. An analysis of
UK data has shown that the proportion of 30-day mortal-
ity falling within the initial admission has actually
decreased over time[7].
A second question is how to attribute deaths after admis-
sion to the cause of death. Hospital mortality rates as a
measure of quality are usually evaluated in terms of the
direct cause of morbidity, but this need not be the true
cause of death. Country statistics of deaths are in most
cases based on national death records. These often take a
different view of the cause of death by taking the patient
history into account, before admission to the hospital.
This opens up room for discrepancy and conflicting inter-
pretations of death rates. Studies in Denmark [8] and the
UK [9] have shown that a fairly large proportion of deaths
after a hospitalization for MI or stroke are attributed to
different causes in death records.
A third question associated with the use of mortality qual-
ity indicators is to what extent patients should be followed
up after discharge, especially if hospital discharge registra-
tions are not linked with each other or with a national
death certificate register, as is the case in the Netherlands.
Without such a link-up the administrative burden of fol-
low-up after discharge is high, with large differences in the
effort hospitals put into this follow-up. For example, the
Dutch Health Care Inspectorate (IGZ) asks hospitals to
collect data on 30-day mortality after admission for myo-
cardial infarction. However, in the last publicized out-
comes for this indicator, [10] about 40% of hospitals
could not provide data on mortality after discharge. An in-
depth analysis of five Dutch hospitals commissioned by
the IGZ [11] revealed that there were also large differences
in the way hospitals interpreted the necessary follow-up
after discharge or transfer, with some settling for includ-
ing transfers, others ignoring these, while others also
included death outside their hospital.
The goal of this study is to assess the importance of these
three questions for the computation of mortality indica-
tors after discharge in the Netherlands for two conditions:
myocardial infarction and stroke. The first question, the
influence of trends in place and time of death on hospital
mortality statistics, will be addressed by classifying death
cases after an hospital admission for these conditions
according to time and place of death. The second ques-
tion, how to attribute deaths after admission to the cause
of death will be addressed by comparing the cause of hos-
pital admission with the cause of death on the death cer-
tificate. The third question, the extent to which patients
should be followed up for the computation of mortality
indicators, will be addressed by computing seven different
mortality indicators which differ in the extension of the
follow-up and the associated administrative burden.
Methods
Records from the Dutch hospital discharge register (LMR)
for the period 1995–2003 were linked to the population
register by Statistics Netherlands. The hospital discharge
register is maintained by Prismant Utrecht. This register
contains discharge data for all Dutch general and aca-
demic hospitals, and contains information on patient-
characteristics (date of birth, gender, place of residence)
and episode characteristics (discharge diagnosis, date of
admission and discharge). More than 87% of all hospital
discharges in this register were successfully linked at the
micro-level to the population register[12] The linkage
techniques and the reliability and usability of this dataset
for statistical research have been described else-
where[13,14].
In addition this combined set was linked to the Dutch
death certificate register, maintained by Statistics Nether-
lands. This was necessary to establish the time and the
cause of death. This linkage was facilitated by the fact that
both datasets use the same personal identifier, thus yield-
ing almost 100% linkage rates after excluding those who
emigrated abroad since admission to the hospital.
Approval for the use of the anonymized patient data was
covered by a general agreement between Statistics Nether-
lands and Prismant. In addition, the Dutch association of
hospitals (NVZ) approved the use of the hospital registra-
tion data for this study. No separate ethical approval was
necessary for the use of these data.BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
Page 3 of 11
(page number not for citation purposes)
This combined dataset was used to analyze the place,
time, cause and rate of death within the first year after an
index-admission for myocardial infarction or stroke
among people aged 35 years and above. Index cases were
defined using the main discharge diagnosis. The LMR uses
the ICD9-CM (Dutch Clinical modification[15]) to regis-
ter discharge diagnosis. Myocardial infarction was defined
as ICD9-CM code 410, stroke as ICD9-CM code 431–434
and code 436.
Inclusion criteria for cases in the analysis were (a) having
a principal diagnosis for myocardial infarction or stroke,
(b) being 35 years or older at the end of the year of admis-
sion. Exclusion criteria were: (1) having another admis-
sion for the specified condition within 365 days before
the index-admission; (2) having no hospital data availa-
ble for any part of the period between 365 days before and
365 days after index admission; (3) ambiguously identi-
fied patients in the linked set in the year before and after
the index-admissions, in order to avoid having adminis-
trative twins or émigrés; (4) if the date of mortality on the
death certificate preceded the date of admission (as was
noticed for 11 MI and 6 stroke patients). The second
exclusion criterion mentioned above was necessary in
order to verify the place of death (inside or outside the
hospital) and to verify that an index-admission was not
preceded within a year by a previous admission. This cri-
terion implied that the first and last year of the dataset
were used for verification purposes only, and did not yield
any index-admissions. The third criterion led to the exclu-
sion of 5% of previously selected cases.
Table 1 sums up some characteristics for selected index-
cases.
For all cases, the time to death was computed by subtract-
ing the date of admission to a hospital from the date of
mortality on the death certificate. All selected index-
admissions were assigned a time of death class (within 0–
29 days after admission, within 30–89 days after admis-
sion, within 90–365 days after admission), counting the
date of admission as zero. For this analysis only those
index cases resulting in death within a year of admission
were used. We used chi-squared tests to detect significant
correlations between year of admission and time of death
and place of death categorizations.
All cases were also assigned a place of death class using
any of four groupings:
-deaths within the index-admission
-deaths within a subsequent admission in the same hospi-
tal as the index-admission
-deaths that occurred in a different hospital
-deaths outside hospital
The cause of death was established using the primary
cause registered on the death certificate, using the ICD-10
classification. Causes of death were grouped into three:
-cause of death attributed to cause of index-admission
-cause of death attributed to a circulation disorder other
than index-condition
-deaths due to other causes
The difference in classification systems used in our mor-
bidity data (ICD-9) and mortality data (ICD-10) caused a
minor problem in establishing the correspondence
between the cause of mortality and the index-condition
for stroke because no exact translation could be made.
We, therefore, decided to compare the outcomes with a
slightly broader ICD-10 definition of stroke [I61–I69],
also including indeterminate types. We used chi-square
analysis to detect significant correlations between year of
admission and cause of death.
In our data follow-up of patients was possible for a year
after discharge. To show the effect of including or exclud-
ing different types of follow-up on mortality rates, we cal-
culated seven different types of mortality rates, for each
year in our dataset. Thirty-day mortality within the initial
admission was easily calculated in addition to three
period (30-, 90- and 365-day) rates were calculated for
deaths in the hospital setting only (including transfers
and readmissions) and for deaths outside the hospital.
The denominator for each rate was the total number of
admissions fulfilling index-conditions, including those
still alive 365 days after the start of the initial admission.
Rates were standardized for age and sex using the compo-
sition of the Dutch clinical hospital population in the year
2000.
Results
Actual linkage rates of hospital discharge records to popu-
lation register data were somewhat higher than average for
the selected cases. Of all admissions in 1996–2003 for
AMI age [35–74] 88.9% could be linked, for 75+ this was
93.2%. For stroke, linkage rates were somewhat lower,
with 88.1% for 35–74 age category and 88.9% for those
aged 75+ (Table 1).
For the period 1996–2003 we included 32,990 deaths
after admission for MI and 47,393 deaths after admission
for stroke in our analysis. Of the MI cases 67.9% of those
aged 35–74 died within the first thirty days after admis-BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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sion, compared to total deaths within a year. For those
aged 75+ this was 66.1%. For stroke age differences were
larger with 67.6% dying within 30 days for ages 35–74
and 60.2% for ages 75+. These proportions are all stable
over time: no significant differences between years were
detected over the period 1996–2003.
Table 2 lists the breakdown of MI deaths in the different
time of death and place of death classes and the year of
admission, (given in two-year bands). Table 3 gives a sim-
ilar breakdown for stroke. Chi-squared tests were used to
detect significant trends over time, these are indicated
within the tables.
For MI the analysis points to a growing importance of 'other
hospitals' as death location for MI, especially for 30-day
mortality. In 1996–1997 about 5.9% of the 30-day mortal-
ity after MI for ages 35–74 occurred in a hospital different
from that of the initial intake, in 2002–2003 this proportion
had significantly risen to 10.9%. This rise was at the expense
of 30-day mortality within the initial admission, the propor-
tion of which fell from 86.8% to 79.7% over the same
period. For ages 75+ a similar trend is found, but somewhat
less strong, although still significant.
No significant changes were detected for MI for other death
locations or different distances between time of admission
Table 1: Characteristics of patients included in analysis & general characteristics Dutch hospitals & Dutch population
Admission characteristics*
period 1996–2003
diagnosis Myocardial infarction Stroke
agegroup [35–74] [75+] [35–74] [75+]
Number of hospital admissions within LMR (before linking) 151,104 60,853 104,222 85,098
Number of hospital admissions within linked LMR 134,272 56,737 91,769 75,656
link yield (%) 88.9 93.2 88.1 88.9
Index cases selected before application mortality restriction 111,204 49,653 75,424 67,118
Index cases selected after application mortality restriction (death within a year of admission) 13,662 19,328 16,089 31,304
Characteristics index-cases
Mean age 60.4 81.0 63.1 81.7
Proportion male (%) 74.5 49.9 60.7 41.8
Length of stay (days) 8.3 9.6 14.8 21.6
Decrease length of stay 1996–2003 (%) -10.2 -7.2 -29.6 -30.4
General characteristics Dutch hospitals†
year
1996 2003
Number of hospitals (general, academic, categorical) 148 129
Number of beds (clinical & day care) 58,135 52,292
Number of clinical admissions (thousands) 1,589 1,602
Number of clinical hospital days (thousands) 15,531 12,757
Number of day care admissions (thousands)§ 705 1,221
Workforce (full time equivalents, thousands) 139 175
General characteristics Dutch population†
year
1996 2003
average population size ages 35–74 7.1 7.9
average population size ages 75+ 0.9 1.0
persons treated in a hospital for cva (ICD9 430–434, 436–438] per 10,000 population‡ 15.1 15.4
persons treated in a hospital for coronary heart disease [ICD9 410–414] per 10,000 population‡ 45.4 39.8
* source: this study
† source: CBS [21]
‡ standardized on Dutch population 1–1–2000.
§ source: LMR. Prismant UtrechtBMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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Table 2: Dutch in-hospital mortality for myocardial infarction 1996–2003: deaths tabulated by age and place of death within 30, 90 and 












Time after admission N % N % N % N % N %
Ages 35–74
deaths in 0–29 days **
1996–1997 2,257 86.8 68 2.6 153 5.9 123 4.7 2,601 100.0
1998–1999 1,967 82.1 69 2.9 207 8.6 153 6.4 2,396 100.0
2000–2001 1,793 79.9 81 3.6 242 10.8 128 5.7 2,244 100.0
2002–2003 1,627 79.7 75 3.7 223 10.9 116 5.7 2,041 100.0
deaths in 30–89 days †
1996–1997 47 10.5 121 27.0 65 14.5 215 48.0 448 100.0
1998–1999 50 14.6 110 32.2 44 12.9 138 40.4 342 100.0
2000–2001 42 12.5 99 29.4 63 18.7 133 39.5 337 100.0
2002–2003 37 11.2 115 34.8 65 19.7 113 34.2 330 100.0
deaths in 90–364 days
1996–1997 4 0.4 317 35.3 137 15.3 439 48.9 897 100.0
1998–1999 3 0.4 242 33.1 110 15.0 376 51.4 731 100.0
2000–2001 3 0.4 247 35.2 113 16.1 338 48.2 701 100.0
2002–2003 5 0.8 203 34.2 94 15.8 292 49.2 594 100.0
Ages 75+
deaths in 0–29 days * † * †
1996–1997 2,956 89.3 79 2.4 87 2.6 188 5.7 3,310 100.0
1998–1999 2,869 88.5 92 2.8 102 3.1 178 5.5 3,241 100.0
2000–2001 2,674 86.4 118 3.8 130 4.2 173 5.6 3,095 100.0
2002–2003 2,618 83.7 119 3.8 168 5.4 222 7.1 3,127 100.0
deaths in 30–89 days
1996–1997 80 14.2 173 30.7 45 8.0 265 47.1 563 100.0
1998–1999 73 12.6 170 29.3 66 11.4 271 46.7 580 100.0
2000–2001 88 15.8 161 28.9 61 11.0 247 44.3 557 100.0
2002–2003 69 12.2 161 28.4 49 8.7 287 50.7 566 100.0
deaths in 90–364 days
1996–1997 5 0.5 368 33.8 103 9.5 613 56.3 1,089 100.0
1998–1999 9 0.9 330 31.8 114 11.0 584 56.3 1,037 100.0
2000–2001 8 0.8 329 31.2 96 9.1 620 58.9 1,053 100.0
2002–2003 7 0.6 377 34.0 88 7.9 638 57.5 1,110 100.0
* 2-sided chi-square test trend significant p < .001.
† 2-sided chi-square test trend significant p < .05BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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Time after admission N % N % N % N % N %
Ages 35–74
deaths in 0–29 days † †
1996–1997 2,609 94.0 31 1.1 80 2.9 56 2.0 2,776 100.0
1998–1999 2,555 94.2 32 1.2 77 2.8 49 1.8 2,713 100.0
2000–2001 2,520 93.3 28 1.0 93 3.4 60 2.2 2,701 100.0
2002–2003 2,463 91.8 46 1.7 86 3.2 87 3.2 2,682 100.0
deaths in 30–89 days **
1996–1997 238 44.8 94 17.7 36 6.8 163 30.7 531 100.0
1998–1999 192 42.0 92 20.1 26 5.7 147 32.2 457 100.0
2000–2001 162 35.8 77 17.0 35 7.7 178 39.4 452 100.0
2002–2003 124 26.1 99 20.8 31 6.5 222 46.6 476 100.0
deaths in 90–364 days * †† †
1996–1997 38 4.3 271 30.7 67 7.6 506 57.4 882 100.0
1998–1999 46 5.3 243 28.2 82 9.5 490 56.9 861 100.0
2000–2001 37 4.8 189 24.5 79 10.2 467 60.5 772 100.0
2002–2003 10 1.3 194 24.7 67 8.5 515 65.5 786 100.0
Ages 75+
deaths in 0–29 days **
1996–1997 4,239 94.7 28 0.6 42 0.9 168 3.8 4,477 100.0
1998–1999 4,375 94.7 30 0.6 53 1.1 161 3.5 4,619 100.0
2000–2001 4,526 93.5 43 0.9 74 1.5 198 4.1 4,841 100.0
2002–2003 4,453 90.4 59 1.2 74 1.5 342 6.9 4,928 100.0
deaths in 30–89 days * † *
1996–1997 668 52.5 97 7.6 19 1.5 488 38.4 1,272 100.0
1998–1999 629 50.2 102 8.1 42 3.3 481 38.4 1,254 100.0
2000–2001 641 49.1 115 8.8 49 3.8 501 38.4 1,306 100.0
2002–2003 413 29.1 143 10.1 28 2.0 836 58.9 1,420 100.0
deaths in 90–364 days **
1996–1997 105 6.0 266 15.1 60 3.4 1,328 75.5 1,759 100.0
1998–1999 184 10.4 274 15.4 81 4.6 1,235 69.6 1,774 100.0
2000–2001 122 6.7 274 15.1 74 4.1 1,350 74.2 1,820 100.0
2002–2003 37 2.0 289 15.8 63 3.4 1,445 78.8 1,834 100.0
* 2-sided chi-square test trend significant p < .001.
† 2-sided chi-square test trend significant p < .05BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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and time of death, with the exception of the proportion of
deaths outside the hospital for ages 35–74 within 30–89
days after admission, this fell from 48.0% in 1996–1997
(215 deaths) to 34.2% in 2002–2003 (113 deaths).
For stroke a different picture emerges. No significant
changes here for deaths in a different hospital, but a sig-
nificant rise for deaths outside the hospital for both age
groups and all three distance to death classes. The rise is
especially strong for the proportion of deaths outside the
hospital within 30–89 days of admission, and seems to be
concentrated in the last years included in the analysis. For
instance for deaths of 75+ within 30–89 days after being
admitted the proportion of deaths outside the hospital
was stable at 38.4% over 1996–2001, but rose steeply to
58.9% in 2002–2003. It is important to note that the
observed 30% fall in average length-of-stay for stroke
patients (Table 1) over the period 1996–2003 also
occurred mainly in the last four years of this period.
Table 4 (MI) and Table 5 (stroke) list deaths for year of
admission, time of death and cause of death. The patterns
for both age groups are very similar, so data are presented
for 35+. For admissions for MI this shows a significant (p
< 0.05) decrease over time in the proportion of deaths
attributed on the death certificate to MI, for all time of
death classes. For deaths within 30-days of admission this
decrease is accompanied by a significant rise in deaths due
to other circulatory disorders and deaths due to other
causes. For stroke only for deaths within 90–364 days of
admission a similar pattern is found. For deaths due to
stroke within 90 days of admission, no significant changes
in the distribution of death cases are observed. For both
MI and stroke, the diagnostic groups which contribute the
most to 'other causes' are neoplasms, disorders of the
endocrine system, and respiratory diseases.
In Table 6 and Table 7, mortality rates are presented for
both types of index-admissions and both age-groups.
Rates were standardized using the average age and sex
composition of the clinical hospital population in 2000.
In addition, we estimated mortality rate changes (as abso-
lute differences between rates) between 1996 and 2003.
Most important observation is that all mortality rates have
fallen over this period, but the magnitude of this fall dif-
fers. For MI, the highest reduction is observed for 30-day
Table 4: Underlying cause of death in people who died after hospital admission for myocardial infarction
Deaths due to AMI [I21-I22] Deaths due to other circulatory
disorders
Deaths due to other causes all causes
Time after 
admission
N% N % N% N %
Ages 35+
deaths in 0–29 
days
** *
1996–1997 4,533 76.7 834 14.1 544 9.2 5,911 100.0
1998–1999 4,219 74.8 863 15.3 555 9.8 5,637 100.0
2000–2001 3,839 71.9 865 16.2 635 11.9 5,339 100.0
2002–2003 3,632 70.3 900 17.4 636 12.3 5,168 100.0
deaths in 30–89 
days
* †
1996–1997 392 38.8 385 38.1 234 23.1 1,011 100.0
1998–1999 323 35.0 384 41.6 215 23.3 922 100.0
2000–2001 310 34.7 350 39.1 234 26.2 894 100.0
2002–2003 263 29.4 377 42.1 256 28.6 896 100.0
deaths in 90–364 
days
**
1996–1997 541 27.2 804 40.5 641 32.3 1,986 100.0
1998–1999 444 25.1 743 42.0 581 32.9 1,768 100.0
2000–2001 394 22.5 697 39.7 663 37.8 1,754 100.0
2002–2003 326 19.1 720 42.3 658 38.6 1,704 100.0
* 2-sided chi-square test trend significant p < .001.
† 2-sided chi-square test trend significant p < .05BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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in-hospital mortality. After including readmission and
transfer cases, this decrease is much less. For instance, hos-
pital mortality after MI for ages 35–74 has fallen from 7.1
to 5.8 percent, over 1996–2003, a drop of 1.3%, including
other 30-day hospital deaths reduces this to 0.9%. Overall
365-day mortality dropped by 1.2%, a larger amount than
both 30-day overall mortality (0.8%) and 90-day overall
mortality (0.8%). For ages 75+ the picture for MI is the
same, but much higher absolute gains in mortality reduc-
tion are found at higher levels of mortality. The 30-day in-
hospital mortality for 75+ has dropped from 24.2% to
20.2%, a drop of 4.1%. Including other 30-day hospital
deaths reduces this drop to 3.1%. Again, 365-day overall
mortality dropped by 3.7% further than 30-day overall
mortality (3.1%) and 90-day mortality (3.4%). Observed
drops in MI-mortality rates occur in most cases gradually
over the entire observation period.
For stroke a slightly different picture emerges. Reduction
of 30-day mortality within the initial admission is lower
than the observed drop for 365 day mortality. For ages
35–74, 30-day mortality within the initial admission has
fallen from 12.3 to 11.4%, a drop of 0.9%, while 365-day
overall mortality has fallen with 1.5%. For ages 75+, 30-
day mortality within the initial admission has fallen from
26.5 to 23.5%, a drop of 3.0%, while 365-day overall
mortality has fallen with 3.8%. For stroke, the observed
reduction occurs in the last two years of the observation
period, but not before.
Discussion
In our introduction we identified three problems con-
nected to the calculation of mortality indicators: influence
of trends in place and time of death on mortality statistics,
discrepancy between cause of admission and cause of
death and administrative difficulties with the follow-up of
patients after discharge.
Some limitations of the study need to be addressed. About
10% of MI and stroke records could not be linked to popu-
lation and death registers, because people had administra-
tive twins. However, research by Statistics Netherlands
indicates that the influence of this on outcomes is limited
[12]. Chances of having an administrative twin are some-
what higher in densely populated areas, and also differ by
age. Another limit is of course that available care options
are strongly influenced by government regulations, in the
Dutch situation for instance the severe restrictions on the
Table 5: Underlying cause of death in people who died after hospital admission for stroke
Deaths due to cva [I61-I69]
excl. subarachnoid
hemorrhage
Deaths due to other
circulatory disorders
Deaths due to other
causes
all causes
Time after admission N % N % N % N %
Ages 35+
deaths in 0–29 days
1996–1997 5,395 74.4 898 12.4 960 13.2 7,253 100.0
1998–1999 5,459 74.5 823 11.2 1,050 14.3 7,332 100.0
2000–2001 5,651 74.9 838 11.1 1,053 14.0 7,542 100.0
2002–2003 5,717 75.1 878 11.5 1,015 13.3 7,610 100.0
deaths in 30–89 days †
1996–1997 1,070 59.3 270 15.0 463 25.7 1,803 100.0
1998–1999 989 57.8 265 15.5 457 26.7 1,711 100.0
2000–2001 1,012 57.6 281 16.0 465 26.5 1,758 100.0
2002–2003 1,036 54.6 311 16.4 549 29.0 1,896 100.0
deaths in 90–364 days † †
1996–1997 1,044 39.5 563 21.3 1,034 39.2 2,641 100.0
1998–1999 1,064 40.4 513 19.5 1,058 40.2 2,635 100.0
2000–2001 1,024 39.5 514 19.8 1,054 40.7 2,592 100.0
2002–2003 931 35.5 529 20.2 1,160 44.3 2,620 100.0
* 2-sided chi-square test trend significant p < .001.
† 2-sided chi-square test trend significant p < .05BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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a) mortality rates ages 35–74
1996–1997 12.3 13.0 13.3 14.5 15.4 16.1 18.8
1998–1999 12.5 13.2 13.4 14.4 15.3 15.9 18.7
2000–2001 12.5 13.2 13.4 14.2 15.2 15.5 18.4
2002–2003 11.4 12.1 12.4 13.1 14.3 14.2 17.3
difference 
2003–1996
-0.9 -0.9 -0.9 -1.4 -1.1 -1.9 -1.5
b) mortality rates ages 75+
1996–1997 26.5 26.9 27.9 31.8 35.8 34.5 46.8
1998–1999 26.5 27.0 27.9 31.7 35.5 35.0 46.3
2000–2001 26.3 26.9 28.0 31.6 35.5 34.4 46.1
2002–2003 23.5 24.2 26.0 27.3 33.4 29.4 43.0
difference 
2003–1996
-3.0 -2.7 -2.0 -4.5 -2.5 -5.1 -3.8
*rates standardized for average Dutch hospital population 2000

































a) mortality rates ages 35–74
1996–1997 7.1 7.7 8.1 8.3 9.3 9.5 11.5
1998–1999 6.6 7.6 8.0 8.3 9.1 9.4 11.2
2000–2001 6.5 7.6 8.0 8.3 9.0 9.4 11.2
2002–2003 5.8 6.9 7.3 7.6 8.3 8.6 10.3
difference 
2003–1996
-1.3 -0.9 -0.8 -0.8 -0.9 -0.9 -1.2
b) mortality rates ages 75+
1996–1997 24.2 25.6 27.1 28.1 31.8 31.8 40.5
1998–1999 23.3 24.9 26.3 27.4 31.0 31.0 39.2
2000–2001 21.7 23.7 25.1 26.3 29.6 29.7 38.1
2002–2003 20.2 22.4 24.1 24.5 28.4 28.1 36.8
difference 
2003–1996
-4.1 -3.2 -3.1 -3.6 -3.4 -3.8 -3.7
*rates standardized for average Dutch hospital population 2000BMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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performance of cardiovascular procedures. However we do
think our results may be of wider applicability. For instance
our outcomes for place, time and cause of death analysis
are for key elements, like the proportion of deaths occur-
ring within the initial admission or the proportion of 30-
day mortality compared to 1 year mortality, very similar to
results of a UK study using data from the Oxford Record
Linkage Study [9]. This is remarkable because of the large
difference between the tax-funded health care system in the
UK and the insurance based system in the Netherlands.
Regarding the question of incorporating transfer cases, we
showed that in the Netherlands the proportion of deaths
occurring after a transfer has grown for MI, especially for
30-day mortality. The proportion of deaths occurring in
another hospital has almost doubled for this group
between 1996 and 2003. However, for stroke transfer
seems not to be an important issue.
Although it is likely the most severe cases with a high risk
of mortality are transferred, it is important to stress that the
observed increase over time in post-transfer deaths for MI
does not necessarily imply an increase over time in mortal-
ity rates for transferred patients. Transfer between hospitals
is not a random process but is driven by differences in the
availability of resources like IC-units, or a difference in
treatment options between hospitals. For instance, in the
Netherlands only a minority of hospitals (~20%) are
allowed to perform percutaneous translumminal coronary
angioplasty (PTCA) after a myocardial infarction. Two
competing explanations are possible here: mortality rates
for cases after transfer are higher because the time between
admission and treatment will be longer in general. But
mortality rates could also be lower due to better treatment
options available in the receiving hospital. Current research
like the Prague-1 study [16,17] suggests that the beneficial
effects of transfer outweigh negative effects.
The second problem, discrepancy between the cause of
hospital admission and the cause of death seems to be an
issue growing in importance for deaths after MI but not
for stroke. Over the observation period the number of
deaths after an MI attributed to another circulatory disease
but especially to 'other causes' has grown significantly.
The reason for this is unknown. Part of the explanation
could be that the accuracy of the death certificates issued
after a MI have improved with more cases in which MI can
be seen as a complication rather than a primary cause
being attributed to the 'true' cause. Another possibility
could be a change in diagnostic procedures or in the case-
mix patients being admitted. Over the period 1996–2003,
the age-standardized rate of persons treated in hospital for
coronary heart disease fell from 45.4 per 10,000 popula-
tion to 39.8 per 10,000 (Table 1). No such decline is
observed for stroke. It could be the case that improved
prevention has especially benefited people with a coro-
nary heart disease.
As for the third area, follow-up difficulties, this analysis
demonstrates that it is possible to calculate a wide range
of hospital mortality indicators using linked morbidity
and mortality data.
Using longer time-frames and adding deaths beyond the
initial admission increases the number of mortality cases
found for both MI and stroke. However, our results show
that there is no substantial difference in trends between
easily computed 30-day in-hospital mortality, and other
indicators which require more effort to compute. All the
indicators point to a decline in hospital mortality for MI
and stroke for the observed period, with most of the
deaths occurring within 30 days of the first admission. For
MI it is advisable to exclude transferred cases from the
computation of mortality indicators, because of the signif-
icant rise of deaths occurring after transport observed over
the study period. This is also in line with emerging litera-
ture where exclusion of transfer cases does not appear to
alter the main conclusions about hospital performance
(Peterson et al [18], Bradley et al (19)). For the specific
evaluation for the effect of transfer on mortality rates of
transferred patients – very likely more severe cases – a sep-
arate indicator could be constructed.
Nonetheless, useful insights can be gathered from comput-
ing other indicators which cover other places of death
beyond index hospitals and longer time frames. Over the
observed period, death rates have dropped. It is interesting
to observe that the absolute gain improvement in 30-day
in-hospital mortality from the period 1996 to 2003 is com-
parable to the absolute improvement in 365-day mortality
(all locations) for MI. This suggests that most of the
improvement in survival is reached within the initial hospi-
tal treatment period, and that this is a long term effect
because no substantial decrease in survival is observed after
these first 30 days, which would be the case of there was
only a short-term effect of better initial treatment. For
stroke the markedly better improved survival rate after one
year (as compared to 30-day mortality) indicates that for
this condition improvement of care after discharge from
the hospital plays a substantial role in the better survival.
The almost universal implementation in the last years of
our observation period of 'stroke units' in the Netherlands,
aimed at optimizing the integration of pre- and post dis-
charge care for stroke, seems to be very successful. For both
MI or stroke, there is room for substantial improvement
due to secondary prevention after the initial event.
This sheds light on a debate in the Dutch research com-
munity [19] about the cause of the declining mortality in
the Netherlands for myocardial infarction: better primaryBMC Health Services Research 2008, 8:52 http://www.biomedcentral.com/1472-6963/8/52
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prevention of hearth disease or better post-myocardial inf-
arction treatment with increased use of angioplasties and
drugs like statins.
Since 30-day in-hospital mortality correlates well with
other types of mortality, it underlines the continuing
importance of this indicator as a measure of hospital per-
formance in terms of MI and stroke treatments they pro-
vide.
Conclusion
More research is needed to link actual hospital processes
to these outcome measures, considering the mixed results
recently reported in the literature [18,20]. Therefore, our
study cautions against expecting too much from the use of
30-day in-hospital mortality as an indicator, as our
research shows it is well worth to study hospital mortality
in the broader context of total mortality, and follow-up
mortality over longer time-frames. Although necessary for
understanding mortality patterns over time, including
within mortality rates deaths which occur outside hospi-
tals and after longer periods following index admissions
remain debatable and may not reflect actual hospital per-
formance but probably mirrors transfer, efficiency, and
other health care policies.
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